File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Hepatic steatosis via controlled attenuation parameter measurements and diabetes contribute to persistent liver fibrosis in the era of long-term nucleoside analogue therapy for chronic hepatitis B

TitleHepatic steatosis via controlled attenuation parameter measurements and diabetes contribute to persistent liver fibrosis in the era of long-term nucleoside analogue therapy for chronic hepatitis B
Authors
Issue Date2017
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
The International Liver Congress 2017 (ILC 2017) — 52nd Annual Meeting of the European Association for the Study of the Liver (EASL). Amsterdam, The Netherlands, 19–23 April 2017. In Journal of Hepatology, 2017, v. 66 n. 1, suppl., p. S694-S695, abstract no. SAT-170 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/246333
ISSN
2017 Impact Factor: 15.04
2015 SCImago Journal Rankings: 4.570
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSeto, WKW-
dc.contributor.authorHui, R-
dc.contributor.authorMak, LYL-
dc.contributor.authorLiu, SHK-
dc.contributor.authorCheung, KSM-
dc.contributor.authorFung, JYY-
dc.contributor.authorWong, DKH-
dc.contributor.authorLai, CL-
dc.contributor.authorYuen, RMF-
dc.date.accessioned2017-09-18T02:26:40Z-
dc.date.available2017-09-18T02:26:40Z-
dc.date.issued2017-
dc.identifier.citationThe International Liver Congress 2017 (ILC 2017) — 52nd Annual Meeting of the European Association for the Study of the Liver (EASL). Amsterdam, The Netherlands, 19–23 April 2017. In Journal of Hepatology, 2017, v. 66 n. 1, suppl., p. S694-S695, abstract no. SAT-170-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/246333-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.titleHepatic steatosis via controlled attenuation parameter measurements and diabetes contribute to persistent liver fibrosis in the era of long-term nucleoside analogue therapy for chronic hepatitis B-
dc.typeConference_Paper-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.emailLiu, SHK: drkliu@hku.hk-
dc.identifier.emailCheung, KSM: cks634@hku.hk-
dc.identifier.emailFung, JYY: jfung@hkucc.hku.hk-
dc.identifier.emailWong, DKH: danywong@hku.hk-
dc.identifier.emailLai, CL: hrmelcl@hkucc.hku.hk-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.authorityCheung, KSM=rp02532-
dc.identifier.authorityFung, JYY=rp00518-
dc.identifier.authorityWong, DKH=rp00492-
dc.identifier.authorityLai, CL=rp00314-
dc.identifier.authorityYuen, RMF=rp00479-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S0168-8278(17)31864-0-
dc.identifier.hkuros278523-
dc.identifier.hkuros272127-
dc.identifier.volume66-
dc.identifier.issue1, suppl.-
dc.identifier.spageS694, abstract no. SAT-
dc.identifier.epageS695, abstract no. SAT-
dc.identifier.isiWOS:000401056601705-
dc.publisher.placeNetherlands-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats